Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,949 | -107,468 | -76,394 | -49,873 | -25,056 |
| Depreciation Amortization | 4,570 | 18,969 | 14,463 | 9,341 | 4,730 |
| Accounts receivable | -1,808 | -495 | 1,975 | -907 | 1,128 |
| Accounts payable and accrued liabilities | N/A | 970 | N/A | N/A | N/A |
| Other Working Capital | -24,807 | 9,834 | -2,199 | 165 | 1,018 |
| Other Operating Activity | 2,089 | 3,215 | -125 | 2,123 | -849 |
| Operating Cash Flow | $-39,905 | $-74,975 | $-62,280 | $-39,151 | $-19,029 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,925 | 53,161 | N/A | N/A | 3,689 |
| PPE Investments | -2,331 | -16,288 | -12,037 | -10,320 | -4,720 |
| Net Acquisitions | N/A | 3,443 | 3,443 | 1,542 | N/A |
| Purchase Of Investment | N/A | N/A | -197,855 | -149,541 | N/A |
| Sale Of Investment | N/A | N/A | 242,082 | 152,096 | N/A |
| Investing Cash Flow | $26,594 | $40,316 | $35,633 | $-6,223 | $-1,031 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,146 | 1,146 | 171 | N/A |
| Debt Repayment | -354 | -2,863 | -1,013 | -360 | -279 |
| Common Stock Issued | 312 | 441 | 376 | 377 | 254 |
| Other Financing Activity | 0 | 40,000 | 40,000 | 40,000 | 40,000 |
| Financing Cash Flow | $-42 | $38,724 | $40,509 | $40,188 | $39,975 |
| Beginning Cash Position | 34,879 | 30,814 | 30,814 | 30,814 | 30,814 |
| End Cash Position | 21,526 | 34,879 | 44,676 | 25,628 | 50,729 |
| Net Cash Flow | $-13,353 | $4,065 | $13,862 | $-5,186 | $19,915 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,905 | -74,975 | -62,280 | -39,151 | -19,029 |
| Capital Expenditure | -2,331 | -16,327 | -12,076 | -10,320 | -4,720 |
| Free Cash Flow | -42,236 | -91,302 | -74,356 | -49,471 | -23,749 |